Musaed Alharbi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Musaed Alharbi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Adnan Hadid
Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
1 shared publication - Fahad Almughaileth
Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
1 shared publication - Hamad Alkhalaf
Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
1 shared publication - Khalid Altirkawi
Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
1 shared publication - Lana A. Shaiba
Department of Pediatrics, College of Medicine, King Saud University
1 shared publication - Nasser Alyousef
Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 12 July 2021
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 9, 674899
COVID-19 Disease in Infants Less Than 90 Days: Case Series
The objective of this study is to describe the clinical presentations, radiological and laboratory findings, and outcomes of COVID-19 disease in infants ≤ 90 days of age at presentation. We conducted a retrospective study of infants in this age group who were found to be SARS-CoV-2 positive. Asymptomatic infants who were identified through routine testing following delivery to COVID-19-positive mothers were excluded. We classified infants according to their presentation: asymptomatic, mildly symptomatic, moderately symptomatic, and severely/critically symptomatic. A total of 36 infants were included. Of them, two were asymptomatic and four had severe/critical presentation. Of the severely symptomatic infants, two were considered as multisystem inflammatory syndrome in children (MIS-C) and there was one death. One infant in the severe symptomatic group presented with cardiac failure, with the possibility of congenital infection. Another infant presented with cardiogenic shock. None of these infants received antiviral medication. The study found that infants ≤ 90 days can present with a severe form of COVID-19 disease. Multisystem inflammatory syndrome in children, although rarely reported in infants, is a possible complication of COVID-19 disease and can be associated with significant morbidity and mortality.
- 12 July 2021
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 9, 674899
Open AccessCOVID-19 Disease in Infants Less Than 90 Days: Case Series
The objective of this study is to describe the clinical presentations, radiological and laboratory findings, and outcomes of COVID-19 disease in infants ≤ 90 days of age at presentation. We conducted a retrospective study of infants in this age group who were found to be SARS-CoV-2 positive. Asymptomatic infants who were identified through routine testing following delivery to COVID-19-positive mothers were excluded. We classified infants according to their presentation: asymptomatic, mildly symptomatic, moderately symptomatic, and severely/critically symptomatic. A total of 36 infants were included. Of them, two were asymptomatic and four had severe/critical presentation. Of the severely symptomatic infants, two were considered as multisystem inflammatory syndrome in children (MIS-C) and there was one death. One infant in the severe symptomatic group presented with cardiac failure, with the possibility of congenital infection. Another infant presented with cardiogenic shock. None of these infants received antiviral medication. The study found that infants ≤ 90 days can present with a severe form of COVID-19 disease. Multisystem inflammatory syndrome in children, although rarely reported in infants, is a possible complication of COVID-19 disease and can be associated with significant morbidity and mortality.